Consensus Development Conference on the Diagnosis of Coronary Heart Disease in People With Diabetes: 10–11 February 1998,
Miami, Florida Diabetes Care September 1998 21:1551-1559; doi:10.2337/diacare.21.9.1551
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections Diabetes Care September 1998 21:1414-1431; doi:10.2337/diacare.21.9.1414
Population-Based Assessment of the Level of Care Among Adults With Diabetes in the U.S Diabetes Care September 1998 21:1432-1438; doi:10.2337/diacare.21.9.1432
A Novel Missense Mutation in the Homeodomain of the Hepatocyte Nuclear Factor-1 α/Maturity-Onset Diabetes of the Young 3 in
a Japanese Early-Onset Type 2 Diabetic Patient and Time-Course of Glucose-Stimulated Insulin Secretion Diabetes Care September 1998 21:1569-1571; doi:10.2337/diacare.21.9.1569
Two-Step Islet Autoantibody Screening for Risk Assessment of Type 1 Diabetes in Relatives Diabetes Care September 1998 21:1445-1450; doi:10.2337/diacare.21.9.1445
Two-Step Islet Autoantibody Screening for Risk Assessment of Type 1 Diabetes in Relatives Diabetes Care September 1998 21:1445-1450; doi:10.2337/diacare.21.9.1445
Population-Based Assessment of the Level of Care Among Adults With Diabetes in the U.S Diabetes Care September 1998 21:1432-1438; doi:10.2337/diacare.21.9.1432
Urinary Albumin Excretion Rate and Glomerular Filtration Rate in Single-Kidney Type 2 Diabetic Patients Diabetes Care September 1998 21:1521-1524; doi:10.2337/diacare.21.9.1521
Irreversibility of the Defect in Glycogen Synthase Activity in Skeletal Muscle From Obese Patients With NIDDM Treated With
Diet and Metformin Diabetes Care September 1998 21:1489-1494; doi:10.2337/diacare.21.9.1489
Two-Step Islet Autoantibody Screening for Risk Assessment of Type 1 Diabetes in Relatives Diabetes Care September 1998 21:1445-1450; doi:10.2337/diacare.21.9.1445
International Diabetes Federation Meeting, 1997: Nephropathy, retinopathy, and glycation Diabetes Care September 1998 21:1560-1566; doi:10.2337/diacare.21.9.1560
Bonet, Rosa
Plasma Lipoprotein(a) Levels Are Not Influenced by Glycemic Control in Type 1 Diabetes Diabetes Care September 1998 21:1517-1520; doi:10.2337/diacare.21.9.1517
Two-Step Islet Autoantibody Screening for Risk Assessment of Type 1 Diabetes in Relatives Diabetes Care September 1998 21:1445-1450; doi:10.2337/diacare.21.9.1445
Two-Step Islet Autoantibody Screening for Risk Assessment of Type 1 Diabetes in Relatives Diabetes Care September 1998 21:1445-1450; doi:10.2337/diacare.21.9.1445
Two-Step Islet Autoantibody Screening for Risk Assessment of Type 1 Diabetes in Relatives Diabetes Care September 1998 21:1445-1450; doi:10.2337/diacare.21.9.1445
An Epitaph for Sulfated Insulin: Immunologic profile of the last patients as they are switched from sulfated beef to human
insulin Diabetes Care September 1998 21:1571-1572; doi:10.2337/diacare.21.9.1571
Insulin Analog Lispro Decreases Insulin Resistance and Improves Glycemic Control in an Obese Patient With Insulin-Requiring
Type 2 Diabetes Diabetes Care September 1998 21:1575; doi:10.2337/diacare.21.9.1575a
Accuracy of Calculated Serum Low-Density Lipoprotein Cholesterol for the Assessment of Coronary Heart Disease Risk in NIDDM
Patients Diabetes Care September 1998 21:1397-1402; doi:10.2337/diacare.21.9.1397
Plasma Lipoprotein(a) Levels Are Not Influenced by Glycemic Control in Type 1 Diabetes Diabetes Care September 1998 21:1517-1520; doi:10.2337/diacare.21.9.1517
Plasma Lipoprotein(a) Levels Are Not Influenced by Glycemic Control in Type 1 Diabetes Diabetes Care September 1998 21:1517-1520; doi:10.2337/diacare.21.9.1517
Increased Familial History of Arterial Hypertension, Coronary Heart Disease, and Renal Disease in Brazilian Type 2 Diabetic
Patients With Diabetic Nephropathy Diabetes Care September 1998 21:1545-1550; doi:10.2337/diacare.21.9.1545
Stratifying Patients at Risk of Diabetic Complications: An integrated look at clinical, socioeconomic, and care-related factors
Diabetes Care September 1998 21:1439-1444; doi:10.2337/diacare.21.9.1439
An Epitaph for Sulfated Insulin: Immunologic profile of the last patients as they are switched from sulfated beef to human
insulin Diabetes Care September 1998 21:1571-1572; doi:10.2337/diacare.21.9.1571
Plasma Lipoprotein(a) Levels Are Not Influenced by Glycemic Control in Type 1 Diabetes Diabetes Care September 1998 21:1517-1520; doi:10.2337/diacare.21.9.1517
Plasma Lipoprotein(a) Levels Are Not Influenced by Glycemic Control in Type 1 Diabetes Diabetes Care September 1998 21:1517-1520; doi:10.2337/diacare.21.9.1517
Stratifying Patients at Risk of Diabetic Complications: An integrated look at clinical, socioeconomic, and care-related factors
Diabetes Care September 1998 21:1439-1444; doi:10.2337/diacare.21.9.1439
Agreement Between Old and New Diagnostic Criteria in Postparhim Testing of Women With Gestational Diabetes Diabetes Care September 1998 21:1579-1580; doi:10.2337/diacare.21.9.1579
Insulin Analog Lispro Decreases Insulin Resistance and Improves Glycemic Control in an Obese Patient With Insulin-Requiring
Type 2 Diabetes Diabetes Care September 1998 21:1575; doi:10.2337/diacare.21.9.1575a
Urinary Albumin Excretion Rate and Glomerular Filtration Rate in Single-Kidney Type 2 Diabetic Patients Diabetes Care September 1998 21:1521-1524; doi:10.2337/diacare.21.9.1521
Hyperglycemia Is a Factor for an Increase in Serum Ceruloplasmin in Type 2 Diabetes Diabetes Care September 1998 21:1525-1528; doi:10.2337/diacare.21.9.1525
Irreversibility of the Defect in Glycogen Synthase Activity in Skeletal Muscle From Obese Patients With NIDDM Treated With
Diet and Metformin Diabetes Care September 1998 21:1489-1494; doi:10.2337/diacare.21.9.1489
Insulin Analog Lispro Decreases Insulin Resistance and Improves Glycemic Control in an Obese Patient With Insulin-Requiring
Type 2 Diabetes Diabetes Care September 1998 21:1575; doi:10.2337/diacare.21.9.1575a
No Differences in Attentional Functioning Between Type 1 Diabetic Patients With and Without a History of Severe Hypoglycemia
Diabetes Care September 1998 21:1568-1569; doi:10.2337/diacare.21.9.1568
Plasma Lipoprotein(a) Levels Are Not Influenced by Glycemic Control in Type 1 Diabetes Diabetes Care September 1998 21:1517-1520; doi:10.2337/diacare.21.9.1517
Two-Step Islet Autoantibody Screening for Risk Assessment of Type 1 Diabetes in Relatives Diabetes Care September 1998 21:1445-1450; doi:10.2337/diacare.21.9.1445
Agreement Between Old and New Diagnostic Criteria in Postparhim Testing of Women With Gestational Diabetes Diabetes Care September 1998 21:1579-1580; doi:10.2337/diacare.21.9.1579
High Prevalence of Albuminuria Among African-Americans With Short Duration of Diabetes Diabetes Care September 1998 21:1576-1577; doi:10.2337/diacare.21.9.1576
Insulin Analog Lispro Decreases Insulin Resistance and Improves Glycemic Control in an Obese Patient With Insulin-Requiring
Type 2 Diabetes Diabetes Care September 1998 21:1575; doi:10.2337/diacare.21.9.1575a
Dissociation of Microangiopathy and Macroangiopathy in Patients With Type 2 Diabetes Diabetes Care September 1998 21:1451-1454; doi:10.2337/diacare.21.9.1451
High Prevalence of Albuminuria Among African-Americans With Short Duration of Diabetes Diabetes Care September 1998 21:1576-1577; doi:10.2337/diacare.21.9.1576
Sympathetic Function Test of Vasoconstrictor Changes in Foot Arteries in Diabetic Patients Diabetes Care September 1998 21:1495-1501; doi:10.2337/diacare.21.9.1495
Population-Based Assessment of the Level of Care Among Adults With Diabetes in the U.S Diabetes Care September 1998 21:1432-1438; doi:10.2337/diacare.21.9.1432
Effect of Hypoglycemia on β-Adrenergic Sensitivity in Normal and Type 1 Diabetic Subjects Diabetes Care September 1998 21:1505-1510; doi:10.2337/diacare.21.9.1505
High Prevalence of Albuminuria Among African-Americans With Short Duration of Diabetes Diabetes Care September 1998 21:1576-1577; doi:10.2337/diacare.21.9.1576
Increased Familial History of Arterial Hypertension, Coronary Heart Disease, and Renal Disease in Brazilian Type 2 Diabetic
Patients With Diabetic Nephropathy Diabetes Care September 1998 21:1545-1550; doi:10.2337/diacare.21.9.1545
Effect of Hypoglycemia on β-Adrenergic Sensitivity in Normal and Type 1 Diabetic Subjects Diabetes Care September 1998 21:1505-1510; doi:10.2337/diacare.21.9.1505
Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 Diabetes Diabetes Care September 1998 21:1462-1469; doi:10.2337/diacare.21.9.1462
Urinary Albumin Excretion Rate and Glomerular Filtration Rate in Single-Kidney Type 2 Diabetic Patients Diabetes Care September 1998 21:1521-1524; doi:10.2337/diacare.21.9.1521
Increased Familial History of Arterial Hypertension, Coronary Heart Disease, and Renal Disease in Brazilian Type 2 Diabetic
Patients With Diabetic Nephropathy Diabetes Care September 1998 21:1545-1550; doi:10.2337/diacare.21.9.1545
Effect of Hypoglycemia on β-Adrenergic Sensitivity in Normal and Type 1 Diabetic Subjects Diabetes Care September 1998 21:1505-1510; doi:10.2337/diacare.21.9.1505
Hyperglycemia Is a Factor for an Increase in Serum Ceruloplasmin in Type 2 Diabetes Diabetes Care September 1998 21:1525-1528; doi:10.2337/diacare.21.9.1525
Effect of Hypoglycemia on β-Adrenergic Sensitivity in Normal and Type 1 Diabetic Subjects Diabetes Care September 1998 21:1505-1510; doi:10.2337/diacare.21.9.1505
No Differences in Attentional Functioning Between Type 1 Diabetic Patients With and Without a History of Severe Hypoglycemia
Diabetes Care September 1998 21:1568-1569; doi:10.2337/diacare.21.9.1568
Biologic Material in Needles and Cartridges After Insulin Injection With a Pen in Diabetic Patients Diabetes Care September 1998 21:1502-1504; doi:10.2337/diacare.21.9.1502
Irreversibility of the Defect in Glycogen Synthase Activity in Skeletal Muscle From Obese Patients With NIDDM Treated With
Diet and Metformin Diabetes Care September 1998 21:1489-1494; doi:10.2337/diacare.21.9.1489
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections Diabetes Care September 1998 21:1414-1431; doi:10.2337/diacare.21.9.1414
Population-Based Assessment of the Level of Care Among Adults With Diabetes in the U.S Diabetes Care September 1998 21:1432-1438; doi:10.2337/diacare.21.9.1432
Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 Diabetes Diabetes Care September 1998 21:1462-1469; doi:10.2337/diacare.21.9.1462
Irreversibility of the Defect in Glycogen Synthase Activity in Skeletal Muscle From Obese Patients With NIDDM Treated With
Diet and Metformin Diabetes Care September 1998 21:1489-1494; doi:10.2337/diacare.21.9.1489
Sympathetic Function Test of Vasoconstrictor Changes in Foot Arteries in Diabetic Patients Diabetes Care September 1998 21:1495-1501; doi:10.2337/diacare.21.9.1495
A Novel Missense Mutation in the Homeodomain of the Hepatocyte Nuclear Factor-1 α/Maturity-Onset Diabetes of the Young 3 in
a Japanese Early-Onset Type 2 Diabetic Patient and Time-Course of Glucose-Stimulated Insulin Secretion Diabetes Care September 1998 21:1569-1571; doi:10.2337/diacare.21.9.1569
A Novel Missense Mutation in the Homeodomain of the Hepatocyte Nuclear Factor-1 α/Maturity-Onset Diabetes of the Young 3 in
a Japanese Early-Onset Type 2 Diabetic Patient and Time-Course of Glucose-Stimulated Insulin Secretion Diabetes Care September 1998 21:1569-1571; doi:10.2337/diacare.21.9.1569
A Novel Missense Mutation in the Homeodomain of the Hepatocyte Nuclear Factor-1 α/Maturity-Onset Diabetes of the Young 3 in
a Japanese Early-Onset Type 2 Diabetic Patient and Time-Course of Glucose-Stimulated Insulin Secretion Diabetes Care September 1998 21:1569-1571; doi:10.2337/diacare.21.9.1569
Sympathetic Function Test of Vasoconstrictor Changes in Foot Arteries in Diabetic Patients Diabetes Care September 1998 21:1495-1501; doi:10.2337/diacare.21.9.1495
Relationship of Blood Thromboxane-B2 (TxB2) With Lipid Peroxides and Effect of Vitamin E and Placebo Supplementation on TxB2 and Lipid Peroxide Levels in Type 1 Diabetic Patients Diabetes Care September 1998 21:1511-1516; doi:10.2337/diacare.21.9.1511
Relationship of Blood Thromboxane-B2 (TxB2) With Lipid Peroxides and Effect of Vitamin E and Placebo Supplementation on TxB2 and Lipid Peroxide Levels in Type 1 Diabetic Patients Diabetes Care September 1998 21:1511-1516; doi:10.2337/diacare.21.9.1511
A Novel Missense Mutation in the Homeodomain of the Hepatocyte Nuclear Factor-1 α/Maturity-Onset Diabetes of the Young 3 in
a Japanese Early-Onset Type 2 Diabetic Patient and Time-Course of Glucose-Stimulated Insulin Secretion Diabetes Care September 1998 21:1569-1571; doi:10.2337/diacare.21.9.1569
A Novel Missense Mutation in the Homeodomain of the Hepatocyte Nuclear Factor-1 α/Maturity-Onset Diabetes of the Young 3 in
a Japanese Early-Onset Type 2 Diabetic Patient and Time-Course of Glucose-Stimulated Insulin Secretion Diabetes Care September 1998 21:1569-1571; doi:10.2337/diacare.21.9.1569
Hyperglycemia Is a Factor for an Increase in Serum Ceruloplasmin in Type 2 Diabetes Diabetes Care September 1998 21:1525-1528; doi:10.2337/diacare.21.9.1525
Sympathetic Function Test of Vasoconstrictor Changes in Foot Arteries in Diabetic Patients Diabetes Care September 1998 21:1495-1501; doi:10.2337/diacare.21.9.1495
Hyperglycemia Is a Factor for an Increase in Serum Ceruloplasmin in Type 2 Diabetes Diabetes Care September 1998 21:1525-1528; doi:10.2337/diacare.21.9.1525
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections Diabetes Care September 1998 21:1414-1431; doi:10.2337/diacare.21.9.1414
Troglitazone Reduces Plasma Leptin Concentration but Increases Hunger in NIDDM Patients Diabetes Care September 1998 21:1470-1474; doi:10.2337/diacare.21.9.1470
Microdialysis of Glucose in Subcutaneous Adipose Tissue up to 3 Weeks in Healthy Volunteers Diabetes Care September 1998 21:1481-1488; doi:10.2337/diacare.21.9.1481
Relationship of Blood Thromboxane-B2 (TxB2) With Lipid Peroxides and Effect of Vitamin E and Placebo Supplementation on TxB2 and Lipid Peroxide Levels in Type 1 Diabetic Patients Diabetes Care September 1998 21:1511-1516; doi:10.2337/diacare.21.9.1511
A Novel Missense Mutation in the Homeodomain of the Hepatocyte Nuclear Factor-1 α/Maturity-Onset Diabetes of the Young 3 in
a Japanese Early-Onset Type 2 Diabetic Patient and Time-Course of Glucose-Stimulated Insulin Secretion Diabetes Care September 1998 21:1569-1571; doi:10.2337/diacare.21.9.1569
A Novel Missense Mutation in the Homeodomain of the Hepatocyte Nuclear Factor-1 α/Maturity-Onset Diabetes of the Young 3 in
a Japanese Early-Onset Type 2 Diabetic Patient and Time-Course of Glucose-Stimulated Insulin Secretion Diabetes Care September 1998 21:1569-1571; doi:10.2337/diacare.21.9.1569
Biologic Material in Needles and Cartridges After Insulin Injection With a Pen in Diabetic Patients Diabetes Care September 1998 21:1502-1504; doi:10.2337/diacare.21.9.1502
Attitudes of Primary Care Providers Toward Diabetes: Barriers to guideline implementation Diabetes Care September 1998 21:1391-1396; doi:10.2337/diacare.21.9.1391
Insulin Analog Lispro Decreases Insulin Resistance and Improves Glycemic Control in an Obese Patient With Insulin-Requiring
Type 2 Diabetes Diabetes Care September 1998 21:1575; doi:10.2337/diacare.21.9.1575a
An Epitaph for Sulfated Insulin: Immunologic profile of the last patients as they are switched from sulfated beef to human
insulin Diabetes Care September 1998 21:1571-1572; doi:10.2337/diacare.21.9.1571
Biologic Material in Needles and Cartridges After Insulin Injection With a Pen in Diabetic Patients Diabetes Care September 1998 21:1502-1504; doi:10.2337/diacare.21.9.1502
An Epitaph for Sulfated Insulin: Immunologic profile of the last patients as they are switched from sulfated beef to human
insulin Diabetes Care September 1998 21:1571-1572; doi:10.2337/diacare.21.9.1571
Hyperglycemia Is a Factor for an Increase in Serum Ceruloplasmin in Type 2 Diabetes Diabetes Care September 1998 21:1525-1528; doi:10.2337/diacare.21.9.1525
Sympathetic Function Test of Vasoconstrictor Changes in Foot Arteries in Diabetic Patients Diabetes Care September 1998 21:1495-1501; doi:10.2337/diacare.21.9.1495
Relationship of Blood Thromboxane-B2 (TxB2) With Lipid Peroxides and Effect of Vitamin E and Placebo Supplementation on TxB2 and Lipid Peroxide Levels in Type 1 Diabetic Patients Diabetes Care September 1998 21:1511-1516; doi:10.2337/diacare.21.9.1511
Two-Step Islet Autoantibody Screening for Risk Assessment of Type 1 Diabetes in Relatives Diabetes Care September 1998 21:1445-1450; doi:10.2337/diacare.21.9.1445
Sympathetic Function Test of Vasoconstrictor Changes in Foot Arteries in Diabetic Patients Diabetes Care September 1998 21:1495-1501; doi:10.2337/diacare.21.9.1495
Troglitazone Reduces Plasma Leptin Concentration but Increases Hunger in NIDDM Patients Diabetes Care September 1998 21:1470-1474; doi:10.2337/diacare.21.9.1470
Agreement Between Old and New Diagnostic Criteria in Postparhim Testing of Women With Gestational Diabetes Diabetes Care September 1998 21:1579-1580; doi:10.2337/diacare.21.9.1579
A Novel Missense Mutation in the Homeodomain of the Hepatocyte Nuclear Factor-1 α/Maturity-Onset Diabetes of the Young 3 in
a Japanese Early-Onset Type 2 Diabetic Patient and Time-Course of Glucose-Stimulated Insulin Secretion Diabetes Care September 1998 21:1569-1571; doi:10.2337/diacare.21.9.1569
Population-Based Assessment of the Level of Care Among Adults With Diabetes in the U.S Diabetes Care September 1998 21:1432-1438; doi:10.2337/diacare.21.9.1432
A Novel Missense Mutation in the Homeodomain of the Hepatocyte Nuclear Factor-1 α/Maturity-Onset Diabetes of the Young 3 in
a Japanese Early-Onset Type 2 Diabetic Patient and Time-Course of Glucose-Stimulated Insulin Secretion Diabetes Care September 1998 21:1569-1571; doi:10.2337/diacare.21.9.1569
Stratifying Patients at Risk of Diabetic Complications: An integrated look at clinical, socioeconomic, and care-related factors
Diabetes Care September 1998 21:1439-1444; doi:10.2337/diacare.21.9.1439
Sympathetic Function Test of Vasoconstrictor Changes in Foot Arteries in Diabetic Patients Diabetes Care September 1998 21:1495-1501; doi:10.2337/diacare.21.9.1495
Comparison of Percent Total GHb With Percent HbA1c in People With and Without Known Diabetes Diabetes Care September 1998 21:1475-1480; doi:10.2337/diacare.21.9.1475
Hyperglycemia Is a Factor for an Increase in Serum Ceruloplasmin in Type 2 Diabetes Diabetes Care September 1998 21:1525-1528; doi:10.2337/diacare.21.9.1525
Dissociation of Microangiopathy and Macroangiopathy in Patients With Type 2 Diabetes Diabetes Care September 1998 21:1451-1454; doi:10.2337/diacare.21.9.1451
Sympathetic Function Test of Vasoconstrictor Changes in Foot Arteries in Diabetic Patients Diabetes Care September 1998 21:1495-1501; doi:10.2337/diacare.21.9.1495
Insulin Analog Lispro Decreases Insulin Resistance and Improves Glycemic Control in an Obese Patient With Insulin-Requiring
Type 2 Diabetes Diabetes Care September 1998 21:1575; doi:10.2337/diacare.21.9.1575a
On behalf of the SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration
Stratifying Patients at Risk of Diabetic Complications: An integrated look at clinical, socioeconomic, and care-related factors
Diabetes Care September 1998 21:1439-1444; doi:10.2337/diacare.21.9.1439
Plasma Lipoprotein(a) Levels Are Not Influenced by Glycemic Control in Type 1 Diabetes Diabetes Care September 1998 21:1517-1520; doi:10.2337/diacare.21.9.1517
Relationship of Blood Thromboxane-B2 (TxB2) With Lipid Peroxides and Effect of Vitamin E and Placebo Supplementation on TxB2 and Lipid Peroxide Levels in Type 1 Diabetic Patients Diabetes Care September 1998 21:1511-1516; doi:10.2337/diacare.21.9.1511
Increased Left Ventricular Mass in Normotensive Type 1 Diabetic Patients With Diabetic Nephropathy Diabetes Care September 1998 21:1534-1539; doi:10.2337/diacare.21.9.1534
Two-Step Islet Autoantibody Screening for Risk Assessment of Type 1 Diabetes in Relatives Diabetes Care September 1998 21:1445-1450; doi:10.2337/diacare.21.9.1445
Plasma Lipoprotein(a) Levels Are Not Influenced by Glycemic Control in Type 1 Diabetes Diabetes Care September 1998 21:1517-1520; doi:10.2337/diacare.21.9.1517
Biologic Material in Needles and Cartridges After Insulin Injection With a Pen in Diabetic Patients Diabetes Care September 1998 21:1502-1504; doi:10.2337/diacare.21.9.1502
High Prevalence of Albuminuria Among African-Americans With Short Duration of Diabetes Diabetes Care September 1998 21:1576-1577; doi:10.2337/diacare.21.9.1576
Assessing Dependency in Insulin-Treated Patients With Diabetes Supported by a Community Nursing Service Diabetes Care September 1998 21:1567; doi:10.2337/diacare.21.9.1567a
Attitudes of Primary Care Providers Toward Diabetes: Barriers to guideline implementation Diabetes Care September 1998 21:1391-1396; doi:10.2337/diacare.21.9.1391
Effect of Hypoglycemia on β-Adrenergic Sensitivity in Normal and Type 1 Diabetic Subjects Diabetes Care September 1998 21:1505-1510; doi:10.2337/diacare.21.9.1505
Accuracy of Calculated Serum Low-Density Lipoprotein Cholesterol for the Assessment of Coronary Heart Disease Risk in NIDDM
Patients Diabetes Care September 1998 21:1397-1402; doi:10.2337/diacare.21.9.1397
Increased Left Ventricular Mass in Normotensive Type 1 Diabetic Patients With Diabetic Nephropathy Diabetes Care September 1998 21:1534-1539; doi:10.2337/diacare.21.9.1534
Troglitazone Reduces Plasma Leptin Concentration but Increases Hunger in NIDDM Patients Diabetes Care September 1998 21:1470-1474; doi:10.2337/diacare.21.9.1470
Effect of Hypoglycemia on β-Adrenergic Sensitivity in Normal and Type 1 Diabetic Subjects Diabetes Care September 1998 21:1505-1510; doi:10.2337/diacare.21.9.1505
Microdialysis of Glucose in Subcutaneous Adipose Tissue up to 3 Weeks in Healthy Volunteers Diabetes Care September 1998 21:1481-1488; doi:10.2337/diacare.21.9.1481
Two-Step Islet Autoantibody Screening for Risk Assessment of Type 1 Diabetes in Relatives Diabetes Care September 1998 21:1445-1450; doi:10.2337/diacare.21.9.1445
Sympathetic Function Test of Vasoconstrictor Changes in Foot Arteries in Diabetic Patients Diabetes Care September 1998 21:1495-1501; doi:10.2337/diacare.21.9.1495
Troglitazone Reduces Plasma Leptin Concentration but Increases Hunger in NIDDM Patients Diabetes Care September 1998 21:1470-1474; doi:10.2337/diacare.21.9.1470
Troglitazone Reduces Plasma Leptin Concentration but Increases Hunger in NIDDM Patients Diabetes Care September 1998 21:1470-1474; doi:10.2337/diacare.21.9.1470
Effect of Hypoglycemia on β-Adrenergic Sensitivity in Normal and Type 1 Diabetic Subjects Diabetes Care September 1998 21:1505-1510; doi:10.2337/diacare.21.9.1505
Urinary Albumin Excretion Rate and Glomerular Filtration Rate in Single-Kidney Type 2 Diabetic Patients Diabetes Care September 1998 21:1521-1524; doi:10.2337/diacare.21.9.1521
Assessing Dependency in Insulin-Treated Patients With Diabetes Supported by a Community Nursing Service Diabetes Care September 1998 21:1567; doi:10.2337/diacare.21.9.1567a
Relationship of Blood Thromboxane-B2 (TxB2) With Lipid Peroxides and Effect of Vitamin E and Placebo Supplementation on TxB2 and Lipid Peroxide Levels in Type 1 Diabetic Patients Diabetes Care September 1998 21:1511-1516; doi:10.2337/diacare.21.9.1511
No Differences in Attentional Functioning Between Type 1 Diabetic Patients With and Without a History of Severe Hypoglycemia
Diabetes Care September 1998 21:1568-1569; doi:10.2337/diacare.21.9.1568
Accuracy of Calculated Serum Low-Density Lipoprotein Cholesterol for the Assessment of Coronary Heart Disease Risk in NIDDM
Patients Diabetes Care September 1998 21:1397-1402; doi:10.2337/diacare.21.9.1397
Effect of Hypoglycemia on β-Adrenergic Sensitivity in Normal and Type 1 Diabetic Subjects Diabetes Care September 1998 21:1505-1510; doi:10.2337/diacare.21.9.1505
Hyperglycemia Is a Factor for an Increase in Serum Ceruloplasmin in Type 2 Diabetes Diabetes Care September 1998 21:1525-1528; doi:10.2337/diacare.21.9.1525
Sympathetic Function Test of Vasoconstrictor Changes in Foot Arteries in Diabetic Patients Diabetes Care September 1998 21:1495-1501; doi:10.2337/diacare.21.9.1495
A Novel Missense Mutation in the Homeodomain of the Hepatocyte Nuclear Factor-1 α/Maturity-Onset Diabetes of the Young 3 in
a Japanese Early-Onset Type 2 Diabetic Patient and Time-Course of Glucose-Stimulated Insulin Secretion Diabetes Care September 1998 21:1569-1571; doi:10.2337/diacare.21.9.1569
Increased Left Ventricular Mass in Normotensive Type 1 Diabetic Patients With Diabetic Nephropathy Diabetes Care September 1998 21:1534-1539; doi:10.2337/diacare.21.9.1534
High Prevalence of Albuminuria Among African-Americans With Short Duration of Diabetes Diabetes Care September 1998 21:1576-1577; doi:10.2337/diacare.21.9.1576
Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 Diabetes Diabetes Care September 1998 21:1462-1469; doi:10.2337/diacare.21.9.1462
Accuracy of Calculated Serum Low-Density Lipoprotein Cholesterol for the Assessment of Coronary Heart Disease Risk in NIDDM
Patients Diabetes Care September 1998 21:1397-1402; doi:10.2337/diacare.21.9.1397
Troglitazone Reduces Plasma Leptin Concentration but Increases Hunger in NIDDM Patients Diabetes Care September 1998 21:1470-1474; doi:10.2337/diacare.21.9.1470
Irreversibility of the Defect in Glycogen Synthase Activity in Skeletal Muscle From Obese Patients With NIDDM Treated With
Diet and Metformin Diabetes Care September 1998 21:1489-1494; doi:10.2337/diacare.21.9.1489
No Differences in Attentional Functioning Between Type 1 Diabetic Patients With and Without a History of Severe Hypoglycemia
Diabetes Care September 1998 21:1568-1569; doi:10.2337/diacare.21.9.1568
Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 Diabetes Diabetes Care September 1998 21:1462-1469; doi:10.2337/diacare.21.9.1462
Microdialysis of Glucose in Subcutaneous Adipose Tissue up to 3 Weeks in Healthy Volunteers Diabetes Care September 1998 21:1481-1488; doi:10.2337/diacare.21.9.1481
Microdialysis of Glucose in Subcutaneous Adipose Tissue up to 3 Weeks in Healthy Volunteers Diabetes Care September 1998 21:1481-1488; doi:10.2337/diacare.21.9.1481
An Epitaph for Sulfated Insulin: Immunologic profile of the last patients as they are switched from sulfated beef to human
insulin Diabetes Care September 1998 21:1571-1572; doi:10.2337/diacare.21.9.1571
Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 Diabetes Diabetes Care September 1998 21:1462-1469; doi:10.2337/diacare.21.9.1462
Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 Diabetes Diabetes Care September 1998 21:1462-1469; doi:10.2337/diacare.21.9.1462
Microdialysis of Glucose in Subcutaneous Adipose Tissue up to 3 Weeks in Healthy Volunteers Diabetes Care September 1998 21:1481-1488; doi:10.2337/diacare.21.9.1481
Population-Based Assessment of the Level of Care Among Adults With Diabetes in the U.S Diabetes Care September 1998 21:1432-1438; doi:10.2337/diacare.21.9.1432
An Epitaph for Sulfated Insulin: Immunologic profile of the last patients as they are switched from sulfated beef to human
insulin Diabetes Care September 1998 21:1571-1572; doi:10.2337/diacare.21.9.1571
Agreement Between Old and New Diagnostic Criteria in Postparhim Testing of Women With Gestational Diabetes Diabetes Care September 1998 21:1579-1580; doi:10.2337/diacare.21.9.1579
Dissociation of Microangiopathy and Macroangiopathy in Patients With Type 2 Diabetes Diabetes Care September 1998 21:1451-1454; doi:10.2337/diacare.21.9.1451
Dissociation of Microangiopathy and Macroangiopathy in Patients With Type 2 Diabetes Diabetes Care September 1998 21:1451-1454; doi:10.2337/diacare.21.9.1451
Hyperglycemia Is a Factor for an Increase in Serum Ceruloplasmin in Type 2 Diabetes Diabetes Care September 1998 21:1525-1528; doi:10.2337/diacare.21.9.1525
High Prevalence of Albuminuria Among African-Americans With Short Duration of Diabetes Diabetes Care September 1998 21:1576-1577; doi:10.2337/diacare.21.9.1576